Purpose of Screening Programme Sample Clauses

Purpose of Screening Programme. 1.1 Purpose of the Specification A common national service specification must be used to provide, monitor and govern the NHS Fetal Anomaly Screening Programme (FASP). This enables a consistent and equitable approach across England. The purpose of the service specification is to outline the service and quality indicators expected by NHS England and NHS Improvement for the population for whom it is responsible and which meets the policies, recommendations and standards of the NHS Screening Programmes. The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions which may apply, e.g. the Health and Social Care Act 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification should be read in conjunction with: • Service Specification Number 17 Fetal Anomaly Screening • FASP screening standards • Antenatal and newborn screening key performance indicators (KPIs) • FASP Ultrasound Practitioners Handbook • FASP Laboratory Handbook • FASP Screening Programme Handbook • Managing Safety Incidents in the English NHS National Screening Programmes • NHS England Serious Incident Framework • FASP Checks and audits to improve quality and reduce risks • National Institute for Health and Clinical Excellence (NICE) Clinical guideline 62 Antenatal care • National Institute for Health and Clinical Excellence (NICE) Clinical guideline CG 129 Antenatal care for twin and triplet pregnancies • Royal College of Radiologists. Standards for provision of an ultrasound service • Guidelines for the safe use of diagnostic ultrasound. British Medical Ultrasound Society The national screening team in Public Health England (PHE Screening) provides expert advice and support to the NHS Screening Programme. It does those things which make sense to do once rather than by each individual screening service. This includes: • developing and monitoring standards • producing public information leaflets • quality assurance of local screening services • developing and commissioning training and education‌‌‌‌‌ Providers should subscribe to the PHE Screening blog for the latest national news and updates. National documentation and guidance is published on XXX.XX.
Sample 1
AutoNDA by SimpleDocs
Purpose of Screening Programme. 1.1. Purpose of the Specification To ensure a consistent and equitable approach across England a common national service specification must be used to govern the provision and monitoring of the linked antenatal and newborn NHS Sickle Cell and Thalassaemia (SCT) Screening Programme. The purpose of the service specification is to outline the service and quality indicators expected by NHS England (NHS E) for NHS England responsible population and which meets the policies, recommendations and standards of the NHS Screening Programmes. The service specification is not designed to replicate, duplicate or supersede any relevant legislative provisions which may apply, e.g. the Health and Social Care Act 2008 or the work undertaken by the Care Quality Commission. The specification will be reviewed and amended in line with any new guidance as quickly as possible. This specification needs to be read in conjunction with the following: SCT Screening Programme Standards xxxx://xxx.xxxxxxxxx.xxx.xx/standards xxxxx://xxx.xxx.xx/government/collections/nhs-population-screening-programme- standards Sickle Cell and Thalassaemia Handbook for Laboratories xxxxx://xxx.xxx.xx/government/publications/sickle-cell-and-thalassaemia-screening- handbook-for-laboratories NHS Newborn Blood Spot Screening Programme service specification xxxxx://xxx.xxx.xx/government/publications/public-health-commissioning-in-the-nhs- 2015-to-2016 Specialised Haemoglobinopathy Services definition as set out in the Manual for prescribed specialised services xxxx://xxx.xxxxxxx.xxx.xx/wp-content/uploads/2012/12/pss-manual.pdf The Specification for Specialised Services for Haemoglobinopathy Care (All Ages) (B08/S/a) xxxx://xxx.xxxxxxx.xxx.xx/wp-content/uploads/2013/06/b08-speci-serv-haemo.pdf NICE Clinical Guideline 110. Pregnancy and Social Complex Factors: A Model for Service Provision for Pregnant Women with Complex Social Factors. xxxxx://xxx.xxxx.xxx.xx/guidance/cg110 Guidance and updates on KPIs xxxxx://xxx.xxx.xx/government/collections/nhs- screening-programmes-national-data-reporting NHS Screening Programmes guidance, Managing Serious Incidents in the English NHS National Screening Programmes xxxxx://xxx.xxx.xx/government/publications/managing-safety-incidents-in-nhs- screening-programmes Who pays for what: Aspects of the maternity pathway payment for the screening and immunisation programmes June 2015 xxxxx://xxx.xxxxxxx.xxx.xx/expo/wp-content/uploads/sites/18/2015/06/who-pays-mpp- upd-06-2015.pdf
Sample 1
Purpose of Screening Programme 
Sample 1Sample 2Sample 3See All (7)

Related to Purpose of Screening Programme

  • Training Program It is agreed that there shall be an Apprenticeship Training Program, the provisions of which are set forth in Exhibit "C", which is attached hereto and forms part of this Agreement.

  • Drug Testing Procedures a. The testing procedures and safeguards provided in this policy shall be adhered to by any laboratory personnel administering departmental drug tests.

  • Programme 13.1 Within the time stated in the Contract Data, the Contractor shall submit to the Engineer for approval a Programme showing the general methods, arrangements,' order and timing for all the activities for the construction of works.

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

  • Protocol No action to coerce or censor or penalize any negotiation participant shall be made or implied by any other member as a result of participation in the negotiation process.

  • Testing Procedure A. For alcohol testing, the member shall be first given a breath test, at the collection site, followed by a confirmatory urine test only where the breath test reveals an initial positive alcohol level of .04 grams per 210 l. of breath. If the initial breath test results are below this level, testing shall be discontinued; if confirmatory urine tests results are below a level equivalent to .04 grams per 210 l. of breath, the confirmatory test shall be considered negative.

  • Evaluation, Testing, and Monitoring 1. The System Agency may review, test, evaluate and monitor Grantee’s Products and services, as well as associated documentation and technical support for compliance with the Accessibility Standards. Review, testing, evaluation and monitoring may be conducted before and after the award of a contract. Testing and monitoring may include user acceptance testing. Neither the review, testing (including acceptance testing), evaluation or monitoring of any Product or service, nor the absence of review, testing, evaluation or monitoring, will result in a waiver of the State’s right to contest the Grantee’s assertion of compliance with the Accessibility Standards.

  • Screening 3.13.1 Refuse containers located outside the building shall be fully screened from adjacent properties and from streets by means of opaque fencing or masonry walls with suitable landscaping.

  • Training Programs All employees shall successfully complete all necessary training prior to being assigned work (e.g., all employees will complete health and safety training prior to being assigned to task). Nothing in this Article or provision shall constitute a waiver of either party’s bargaining obligations or defenses. The Employer still has an obligation to notify and bargain changes in terms and conditions of employment with the exclusive representative.

  • Joint Network Implementation and Grooming Process Upon request of either Party, the Parties shall jointly develop an implementation and grooming process (the “Joint Grooming Process” or “Joint Process”) which may define and detail, inter alia:

Time is Money Join Law Insider Premium to draft better contracts faster.